FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

Volume: 17, Issue: 6, Pages: 801 - 810
Published: Jun 1, 2016
Abstract
Summary null Background null 35% of patients with pancreatic cancer have unresectable locally advanced disease at diagnosis. Several studies have examined systemic chemotherapy with FOLFIRINOX (leucovorin and fluorouracil plus irinotecan and oxaliplatin) in patients with locally advanced pancreatic cancer. We aimed to assess the effectiveness of FOLFIRINOX as first-line treatment in this patient population. null Methods null We systematically...
Paper Details
Title
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Published Date
Jun 1, 2016
Volume
17
Issue
6
Pages
801 - 810
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.